GMO U.S. Value ETF (NYSEARCA:GMOV) Short Interest Update

GMO U.S. Value ETF (NYSEARCA:GMOV) was the target of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totaling 8,785 shares, a decrease of 35.4% from the June 15th total of 13,609 shares. Based on an average daily volume of 15,506 shares, the short-interest ratio is presently 0.6 days. Approximately 0.3% of the company’s shares are sold short.

GMO U.S. Value ETF Trading Down 0.1%

Shares of GMOV opened at $31.05 on Friday. The business’s 50-day moving average price is $30.16 and its 200 day moving average price is $29.15. The stock has a market capitalization of $105.57 million, a P/E ratio of 12.08 and a beta of 0.65. GMO U.S. Value ETF has a 1-year low of $24.79 and a 1-year high of $31.29.

Institutional Investors Weigh In On GMO U.S. Value ETF

A number of large investors have recently made changes to their positions in the company. Legacy Capital Wealth Partners LLC lifted its position in shares of GMO U.S. Value ETF by 6.8% in the 4th quarter. Legacy Capital Wealth Partners LLC now owns 96,504 shares of the company’s stock valued at $2,653,000 after acquiring an additional 6,156 shares in the last quarter. HighTower Advisors LLC grew its position in GMO U.S. Value ETF by 1.8% during the 4th quarter. HighTower Advisors LLC now owns 123,110 shares of the company’s stock worth $3,384,000 after purchasing an additional 2,182 shares in the last quarter. RPS Advisory Solutions LLC purchased a new position in GMO U.S. Value ETF during the 4th quarter worth approximately $484,000. Aspen Investment Management Inc acquired a new stake in GMO U.S. Value ETF during the 4th quarter valued at $333,000. Finally, J.W. Cole Advisors Inc. raised its stake in GMO U.S. Value ETF by 128.7% during the 4th quarter. J.W. Cole Advisors Inc. now owns 28,510 shares of the company’s stock valued at $784,000 after purchasing an additional 16,044 shares during the period.

About GMO U.S. Value ETF

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.